JPRN-UMIN000049131
Completed
未知
A survey of treatment practice for patients with neuromyelitis optica spectrum disorder under satralizumab treatment using Japanese claims database - A survey of treatment practice for patients with NMOSD under satralizumab treatment using Japanese claims database
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- neuromyelitis optica spectrum disorder (NMOSD)
- Sponsor
- CHUGAI PHARMACEUTICAL CO.,LTD.
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of treatment regimes in patients with cystic fibrosis and pulmonary excerbations (PEx)E84.0Cystic fibrosis with pulmonary manifestationsDRKS00012924Klinik für Pädiatrie m. S. Pneumologie und ImmunologieCampus Rudolf Virchow Klinikum100
Not yet recruiting
Not Applicable
Case-series study of experience in the treatment of ulcerative colitis with Three Illustrious Senior Traditional Chinese Medicine Doctors in Beijingulcerative colitisITMCTR1900002542Beijing University of Chinese Medicine
Recruiting
Not Applicable
Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease - A Prospective Observational StudyJPRN-UMIN000043154Hamamatsu University School of Medicine400
Not yet recruiting
Not Applicable
Retrospective study on the treatment of patients in specialized outpatient pain therapyChronic PainDRKS00031186Charité - Universitätsmedizin Berlin3,000
Active, not recruiting
Not Applicable
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphomaEUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI